MKI67 and neoplasm: Spatially heterogeneous cancer cell proliferation [inferred from tumor cell expression of Ki-67 (14) and phosphorylated ERK (15)] as well as lesion vascularity (CD31; ref. 16), fosters viable and hypoxic tissue regions.